Elevance Health Inc. (ELV) Stock Analysis

Elevance Health Inc. (ELV) Stock Analysis — AI Research | MarketCI

ELV

Market Closed

Elevance Health Inc.

NYSEHealthcare Medical - Healthcare Plans

104.20K employees

CEO: Gail Koziara Boudreaux

Founded: 2001

$388.50

+$0.00(+NaN%)

Market Cap

84.37B

Beta

0.68

52W Range

N/A

Dividend Yield

1.77%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

ELV Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for ELV built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$1,147.93

AI Price Target

Machine learning • Price prediction

$327.46

Market Sentiment

News & social media analysis

0.49

Value Investor Price

Classic value analysis

$189.31

Financial Health

Bankruptcy risk assessment

3.00

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting ELV investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

54.76% Good

Conditions Met

23.00/42.00

Due Diligence Score

54.76%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions